UBS Group AG - IMMUNOME INC ownership

IMMUNOME INC's ticker is IMNM and the CUSIP is 45257U108. A total of 36 filers reported holding IMMUNOME INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNOME INC
ValueSharesWeighting
Q3 2023$117
-98.6%
14
-98.7%
0.00%
Q2 2023$8,369
+11855.7%
1,058
+7457.1%
0.00%
Q1 2023$70
-93.3%
14
-97.0%
0.00%
Q4 2022$1,048
-98.5%
474
-96.9%
0.00%
Q3 2022$68,000
+1600.0%
15,271
+1049.9%
0.00%
Q2 2022$4,000
+300.0%
1,328
+1006.7%
0.00%
Q1 2022$1,000
-96.9%
120
-95.2%
0.00%
Q4 2021$32,0002,491
+17692.9%
0.00%
Q3 2021$0
-100.0%
14
-99.0%
0.00%
Q2 2021$24,000
+60.0%
1,370
+205.8%
0.00%
Q1 2021$15,000
+50.0%
448
-56.7%
0.00%
Q4 2020$10,0001,0340.00%
Other shareholders
IMMUNOME INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prentice Capital Management, LP 112,131$936,2942.88%
Alpine Global Management, LLC 365,971$3,055,8580.77%
Baldwin Investment Management, LLC 25,394$212,0400.04%
Magnus Financial Group LLC 25,759$215,0880.03%
Wealth Architects, LLC 11,110$92,7690.02%
Point72 Asset Management, L.P. 545,919$4,558,4240.01%
Dorsey Wright & Associates 3,100$25,8850.01%
ACADIAN ASSET MANAGEMENT LLC 49,712$4140.00%
Newbridge Financial Services Group, Inc. 225$1,8790.00%
TD ASSET MANAGEMENT INC 127,280$1,062,7880.00%
View complete list of IMMUNOME INC shareholders